Literature DB >> 12729839

Taurine reduces ammonia- and N-methyl-D-aspartate-induced accumulation of cyclic GMP and hydroxyl radicals in microdialysates of the rat striatum.

Wojciech Hilgier1, Elmira Anderzhanova, Simo S Oja, Pirjo Saransaari, Jan Albrecht.   

Abstract

Acute ammonia neurotoxicity caused by intraperitoneal administration of ammonium salts is mediated by overactivation of N-methyl-D-aspartate (NMDA) receptors, with ensuing generation of free radicals and extracellular accumulation of cyclic GMP (cGMP) arising from stimulation of nitric oxide (NO) synthesis. In this study, infusion of ammonium chloride or NMDA into the striata of rats via microdialysis probes increased the contents of cyclic GMP and hydroxyl radicals in the microdialysates. Co-infusion of taurine virtually abolished both the ammonia- and NMDA-induced accumulation of cGMP. Taurine also attenuated accumulation of hydroxyl radicals evoked by either treatment. This result is the first evidence of a potential of taurine to attenuate the effects of NMDA receptor overactivation by ammonia in vivo and points to the inhibition of the NMDA receptor-mediated NO synthesis as a possible mechanism of its neuroprotective action. Taurine or its blood-brain barrier penetrating analogues may be applicable in treatment of ammonia-induced neurological deficits.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729839     DOI: 10.1016/s0014-2999(03)01667-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  18 in total

Review 1.  Role of astrocytes in brain function and disease.

Authors:  Marta Sidoryk-Wegrzynowicz; Michal Wegrzynowicz; Eunsook Lee; Aaron B Bowman; Michael Aschner
Journal:  Toxicol Pathol       Date:  2010-11-12       Impact factor: 1.902

Review 2.  Oxidative stress in the pathogenesis of hepatic encephalopathy.

Authors:  M D Norenberg; A R Jayakumar; K V Rama Rao
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

3.  The function of the glutamate-nitric oxide-cGMP pathway in brain in vivo and learning ability decrease in parallel in mature compared with young rats.

Authors:  Blanca Piedrafita; Omar Cauli; Carmina Montoliu; Vicente Felipo
Journal:  Learn Mem       Date:  2007-04-05       Impact factor: 2.460

Review 4.  Taurine interaction with neurotransmitter receptors in the CNS: an update.

Authors:  Jan Albrecht; Arne Schousboe
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

Review 5.  Neurotoxicity of Ammonia.

Authors:  Simo S Oja; Pirjo Saransaari; Esa R Korpi
Journal:  Neurochem Res       Date:  2016-07-28       Impact factor: 3.996

6.  The role of protein kinase C and cyclic AMP in the ammonia-induced shift of the taurine uptake/efflux balance towards efflux in C6 cells.

Authors:  Magdalena Zielińska; Barbara Zabłocka; Anna Dybel; Jan Albrecht
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

Review 7.  Mechanisms, diagnosis and management of hepatic encephalopathy.

Authors:  Ravi Prakash; Kevin D Mullen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08-10       Impact factor: 46.802

8.  Fulminant hepatic failure in rats induces oxidative stress differentially in cerebral cortex, cerebellum and pons medulla.

Authors:  K V Sathyasaikumar; I Swapna; P V B Reddy; Ch R K Murthy; A Dutta Gupta; B Senthilkumaran; P Reddanna
Journal:  Neurochem Res       Date:  2007-03       Impact factor: 3.996

Review 9.  Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

10.  Effect of glutamine synthesis inhibition with methionine sulfoximine on the nitric oxide-cyclic GMP pathway in the rat striatum treated acutely with ammonia: a microdialysis study.

Authors:  Wojciech Hilgier; Michal Wegrzynowicz; Michal Maczewski; Andrzej Beresewicz; Simo S Oja; Pirjo Saransaari; Jan Albrecht
Journal:  Neurochem Res       Date:  2007-08-29       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.